TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
TCRR
Delisted
TCRR was delisted on the 31st of May, 2023.
80 hedge funds and large institutions have $45M invested in TCR2 Therapeutics Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 29 reducing their positions, and 13 closing their positions.
Holders
80
Holders Change
-2
Holders Change %
-2.44%
% of All Funds
1.38%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
11
Increased
15
Reduced
29
Closed
13
Calls
$1.14M
Puts
$429K
Net Calls
+$712K
Net Calls Change
-$624K
Top Buyers
Top Sellers
1 |
1
D.E. Shaw & Co
New York
|
$280K |
2 |
2
Charles Schwab
San Francisco,
California
|
$0 |
3 |
![]()
3
JPMorgan Chase & Co
New York
|
$947K |
4 |
4
Citadel Advisors
Miami,
Florida
|
$346K |
5 |
NM
5
Newtyn Management
New York
|
$1.08M |